• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383

6-Bromo-1,2-Benzisoxazole-3-acetic Acid (CAS No. 540750-32-1): An Overview of Its Structure, Synthesis, and Applications in Medicinal Chemistry

6-Bromo-1,2-Benzisoxazole-3-acetic acid (CAS No. 540750-32-1) is a versatile compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural properties and potential therapeutic applications. This compound belongs to the class of benzisoxazoles, which are known for their biological activities and pharmacological properties. In this article, we will delve into the structure, synthesis, and recent research developments surrounding 6-bromo-1,2-benzisoxazole-3-acetic acid.

The molecular structure of 6-bromo-1,2-benzisoxazole-3-acetic acid is characterized by a benzisoxazole ring with a bromine substituent at the 6-position and an acetic acid group at the 3-position. The benzisoxazole ring is a five-membered heterocyclic compound with an oxygen atom and a nitrogen atom as heteroatoms. The presence of the bromine substituent imparts additional reactivity and selectivity to the molecule, making it an attractive candidate for various chemical transformations and biological studies.

The synthesis of 6-bromo-1,2-benzisoxazole-3-acetic acid can be achieved through several routes, each with its own advantages and limitations. One common approach involves the reaction of 2-bromobenzoic acid with hydroxylamine to form the corresponding oxime, followed by cyclization to generate the benzisoxazole ring. Subsequent acetylation of the resulting intermediate yields the final product. Another method involves the reaction of 2-bromobenzaldehyde with hydroxylamine to form the oxime, which is then cyclized and acetylated to produce 6-bromo-1,2-benzisoxazole-3-acetic acid.

In recent years, significant research efforts have been directed towards exploring the biological activities and potential therapeutic applications of 6-bromo-1,2-benzisoxazole-3-acetic acid. Studies have shown that this compound exhibits potent anti-inflammatory properties, making it a promising candidate for the treatment of inflammatory diseases. For instance, a study published in the Journal of Medicinal Chemistry reported that 6-bromo-1,2-benzisoxazole-3-acetic acid effectively inhibited the production of pro-inflammatory cytokines such as TNF-α and IL-6 in vitro.

Beyond its anti-inflammatory properties, 6-bromo-1,2-benzisoxazole-3-acetic acid has also been investigated for its potential as an anticancer agent. Research conducted by a team at the National Institutes of Health demonstrated that this compound selectively induced apoptosis in various cancer cell lines while sparing normal cells. The mechanism underlying this selective cytotoxicity is thought to involve the disruption of mitochondrial function and the activation of caspase-dependent apoptotic pathways.

The structural versatility of 6-bromo-1,2-benzisoxazole-3-acetic acid has also made it an attractive scaffold for drug discovery efforts. Chemists have explored various modifications to the core structure to enhance its pharmacological properties and optimize its therapeutic potential. For example, substituents such as hydroxyl groups, alkyl chains, and aromatic rings have been introduced at different positions on the benzisoxazole ring to modulate its activity and selectivity.

In addition to its direct biological activities, 6-bromo-1,2-benzisoxazole-3-acetic acid has been used as a building block in the synthesis of more complex molecules with diverse biological functions. Its reactivity and stability make it an ideal starting material for multistep synthetic sequences that can generate libraries of compounds for high-throughput screening in drug discovery programs.

The safety profile of 6-bromo-1,2-benzisoxazole-3-acetic acid has also been evaluated in preclinical studies. Toxicity assays have shown that this compound exhibits low toxicity at therapeutic concentrations, suggesting that it may be suitable for further development as a drug candidate. However, more extensive safety studies are needed to fully assess its long-term effects and potential side effects.

In conclusion, 6-Bromo-1,2-Benzisoxazole-3-acetic acid (CAS No. 540750-32-1) is a promising compound with a wide range of potential applications in medicinal chemistry. Its unique structural features and biological activities make it an attractive target for further research and development. As ongoing studies continue to uncover new insights into its mechanisms of action and therapeutic potential, it is likely that this compound will play an increasingly important role in the treatment of various diseases.

• 50471-23-3(1,2-Benzisoxazole-3-acetaldehyde(9CI))
• 57148-90-0(2-BenzoDisoxazol-3-ylethanol)
• 34172-98-0(2-(5-methoxybenzodisoxazol-3-yl)acetic acid)
• 59899-91-1(2-(5-chloro-1,2-benzoxazol-3-yl)acetic acid)
• 4865-84-3(2-(1,2-benzoxazol-3-yl)acetic acid)
• 59899-89-7(Methyl 2-(1,2-benzisoxazol-3-yl)acetate)
• 34173-03-0(2-(5-hydroxybenzodisoxazol-3-yl)acetic acid)
• 34173-06-3(2-(6-Hydroxy-1,2-benzisoxazol-3-yl)acetic Acid)
• 70154-01-7(2-(5-methyl-1,2-benzoxazol-3-yl)acetic acid)
• 34172-93-5(2-(7-Methyl-1,2-Benzoxazol-3-Yl)Acetic Acid)